In a recent BiomarCaRE (Biomarkers for Cardiovascular Risk Assessment in Europe) study (27), high Lp(a) levels robustly increased the risk of cardiac events in patients with DM, indicating that the Lp(a)-lowering might greatly improve the cardiac outcomes in diabetic patients. Here, LPA is linked to diabetes mellitus.